Table 3 The level of Alzheimer’s disease -specific markers in plasma of patients with Alzheimer’s disease.
From: A novel kit for early diagnosis of Alzheimer’s disease using a fluorescent nanoparticle imaging
Patients | The marker and its plasma level(Unit arbitrary fluorescence intensity, X100) | |||||||
|---|---|---|---|---|---|---|---|---|
No sample | average A | BSA | Aβ monomer | Aβ oligomer | NLRP1 | UCHL1 | STAT3 | |
Tau | Visfatin | IL-13 | SORL1 | Clusterin | ApoE4 | ApoE3 | Nogo-A | |
miR-106b | miR-155 | miR-200a | miR-181a | miR-124b | miR-146b | miR-34a | miR-153 | |
P1 | 12.2 ± 0.1 | 255 ± 23 | 10.2 ± 0.5 | 0.2 ± 0.5 | 200 ± 15 | 412 ± 35 | 360 ± 12 | 650 ± 52 |
180 ± 12 | 132 ± 12 | 890 ± 32 | 160 ± 21 | 150 ± 31 | 210 ± 5 | 190 ± 32 | 190 ± 5 | |
30 ± 5 | 200 ± 5 | 185 ± 11 | 23 ± 5 | 750 ± 25 | 300 ± 11 | 620 ± 42 | 190 ± 15 | |
P2 | ND | 210 ± 2 | 0.2 ± 0.5 | 230 ± 11 | 200 ± 5 | 130 ± 25 | 120 ± 5 | 450 ± 12 |
14 ± 5.22 | 120 ± 25 | 920 ± 16 | 190 ± 2 | 140 ± 20 | 650 ± 100 | 130 ± 5 | 150 ± 25 | |
14 ± 5 | 110 ± 3 | 145 ± 21 | 450 ± 23 | 370 ± 78 | 520 ± 100 | 200 ± 23 | 250 ± 45 | |
P3 | 21 ± 5 | 220 ± 35 | 12 ± 3 | 200 ± 13 | 220 ± 14 | 190 ± 21 | 90 ± 4 | 100 ± 6 |
12 ± 3 | 50 ± 6 | 310 ± 21 | 280 ± 16 | 190 ± 31 | 510 ± 3 | 420 ± 62 | 220 ± 41 | |
210 ± 35 | 250 ± 32 | 180 ± 43 | 14 ± 6 | 50 ± 2 | 290 ± 21 | 90 ± 2 | 40 ± 2 | |
P4 | 21 ± 2 | 210 ± 2 | 16 ± 2 | 620 ± 90 | 21 ± 1 | 310 ± 21 | 110 ± 2 | 220 ± 13 |
70 ± 1 | 230 ± 32 | 510 ± 23 | 190 ± 54 | 16 ± 5 | 150 ± 21 | 310 ± 23 | 230 ± 15 | |
190 ± 21 | 15 ± 4 | 230 ± 41 | 200 ± 11 | 220 ± 11 | 180 ± 31 | 310 ± 41 | 110 ± 3 | |
